dpp4i and glp 1 agonist Cellular Sites Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis: Cell Metabolism The pharmacology of DPP-4 inhibitors

The authors propose that GHK-Cus diverse effects are attributable to its ability to reset the human genome to a healthier state

Salam, I

Who It Is For Patients with stubborn visceral fat that resists diet and exercise Men and women experiencing metabolic slowdown associated with aging Patients with insulin resistance or metabolic syndrome who want to improve metabolic markers Anyone seeking meaningful body recomposition not just weight loss, but shifting the ratio of fat to lean mass Patients who have plateaued on a weight loss program and need a metabolic reset What to Expect Weeks 1-4: Improved energy and exercise tolerance as mitochondrial function improves

Cycle structure: 1 to 3 months on therapy, followed by 2 to 3 months off, with a 5-days-on, 2-days-off weekly schedule

Khavinson VK, Bondarev IE, Butyugov AA